Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression

ConclusionICS class differences in pneumonia risk were observed in terms of pooled effect estimates but it is unlikely that any clinically relevant differences exist. Risk –benefit analysis supports ICS use in moderate-severe COPD.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research